Fluticasone propionate intranasal - OptiNose

Drug Profile

Fluticasone propionate intranasal - OptiNose

Alternative Names: FLU-EDS; OPN-375; Opt-FP; OPTINOSE; OptiNose fluticasone propionate; XHANCE

Latest Information Update: 23 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator OptiNose AS
  • Developer OptiNose
  • Class Analgesics; Androstadienes; Anti-inflammatories; Antiallergics; Antiasthmatics; Glucocorticoids; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Nasal polyps
  • Phase III Sinusitis
  • No development reported Asthma

Most Recent Events

  • 22 Jun 2018 Efficacy and adverse events data from phase III NAVIGATE II and EXCHANGE 12 trial in Nasal polyps (NP) and Chronic rhinosinusitis (CRS) released by OptiNose
  • 07 Jun 2018 Optinose initiates enrolment in a phase III trial for Nasal polyps in USA (NCT03591068)
  • 01 Apr 2018 Launched for Nasal polyps in USA (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top